In this paper, no significant differences were found in ACTH, cortisol levels, and thyroid function tests between FMF patients who had been using IL‐1 antagonists for at least 6 months and those who had not (p > 0.050). This evidence concerns the gene IL1B and familial Mediterranean fever.